Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb studyGiacomo P. Comi, Massimo Filippi, Sámuel Komoly et al.|The Lancet|2008Cited by 276